Synthesis, antifungal activity and antibacterial evaluation of some 3- piperazinylmethyl-5-aryl-1H-1,2,4-triazoles

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 10, 1998, Pages 1019-1023

  Papakonstantinou Garoufalias, Spyroula S ^a   Todoulou, Ourania G ^a   Filippatos, Evangelos C ^a   Papadaki Valiraki, Aspasia E ^a   Chytiroglou Lada, Aekaterini ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

3 Piperazinylmethyl 5 aryl 1H 1,2,4 triazoles, antifungal and antibacterial activities

Indexed keywords

1 (4 FLUOROBENZYL) 3 [4 (4 METHOXYPHENYL)PIPERAZIN 1 YLMETHYL] 5 (4 METHYLPHENYL) 1H 1,2,4 TRIAZOLE; 1 (4 FLUOROBENZYL) 3 [4 (4 METHOXYPHENYL)PIPERAZIN 1 YLMETHYL] 5 PHENYL 1H 1,2,4 TRIAZOLE; KETOCONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CLADOSPORIUM; DRUG SYNTHESIS; MYCOSIS; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BACTERIA; FUNGI; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PIPERAZINES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 0031763552     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gabrielsen, B. et al., J. Med. Chem. 35, 3231 (1992)
2. Todoulou, O. G., Papadaki-Valiraki, A. E., Filippatos, E. C. et al., Eur. J. Med. Chem. 29, 127 (1994)
3. Todoulou, O. G., Papadaki-Valiraki, A. E., Ikeda, S. et al., Eur. J. Med. Chem. 29, 611 (1994)
4. Singh, R., Fiakpui, C., Galpin, J. et al., Eur. J. Med, Chem. 31, 301 (1996)
5. Tsotinis, A., Varvaresou, A., Calogeropoulou, T. et al., Arzneim.-Forsch./Drug Res. 47 (I), 307 (1997)
6. Yüksek, H., Demirbas, A., Ikizler, A. et al., Arzneim.-Forsch./Drug Res. 47 (I), 405 (1997)
7. Massa, S., Ragno, R., Cesare Porretta, G. et al., Arch. Pharm. (Weinheim) 326, 539 (1993)
8. Annual Drug Data Report 717 (1987); G. J. Ellames, A. A. Jaxa-Chamiee (G. D. Searle and Co.) E.P. 214, 632
9. Annual Drug Data Report 717 (1987); G. J. Ellames, A. A. Jaxa-Chamiee (G. D. Searle and Co.) E.P. 214, 632
10. Garoufalias, S., Vysas, A., Fytas, G. et al., Ann. Pharm. Franç. 46, 97 (1988)
11. Papakonstantinou-Garoufalias, S. S., Papadaki-Valiraki, A. E., Chytiroglou-Lada, A., Eur. J. Med. Chem. 27, 835 (1992)
12. Papadaki-Valiraki, A., Papakonstantinou-Garoufalias, S., Marakos, P., II Farmaco 48, 1091 (1993)
13. National Committee for Clinical Laboratory Standards Villanova, Pa. (1983)
14. Ericsson, H. M., Sherris, J. C., Acta Path. Scand. Sect. B. Suppl. 217, 1 (1971)
15. Kirisky, J. A., Yung, D. K., Mahony, D. E., Eur. J. Med. Chem. 21, 1301 (1978)
16. Pinner, A., 'Die Imidoether und ihre Derivate', R. Oppenheim, Berlin (1892)
17. McElvain, S. M., Stevens, C. L., J. Am. Chem. Soc. 68, 1917 (1946)
18. Glickman, S. A., Cope, A. C., J. Am. Chem. Soc. 67, 1017 (1945)
19. Marx, G. S., Spoerri, P. E., J. Org. Chem. 37, 111 (1972)